Zlatomics

Zlatomics has two business divisions: Zlatomics Consulting and Zlatomics R&D. Zlatomics Consulting funds are invested into the research and development of the proprietary biotech innovations under Zlatomics R&D. Zlatomics Consulting is a strategic partnership branch specializing in serving the biotechnology and pharmaceutical industry, academia, governmental agencies, investment institutions, and other consulting practices. It tackles complex challenges in biotechnology and bioentrepreneurship, offering tailored results designed to drive innovation and accelerate biotech discoveries. In today's dynamic market, where scientific options and tasks are ample, funding is tight, and expertise is crucial, Zlatomics provides on-demand access to highly skilled scientist(s) with a deep business understanding, offering a flexible, cost-effective, efficient, all-in-one alternative to full-time hiring. Zlatomics services include R&D (encompassing in-depth scientific research with actionable reporting, including in silico modeling to predict and prioritize high-probability outcomes), consulting, experimental work (site-dependent), collaboration with internal teams in molecular life sciences and related fields, innovative recovery of distressed biotech enterprises, business administration and strategic scientific leadership guidance. Zlatomics scientist(s) with business acumen take on defined roles for specific tasks or projects: the engagements are often short-term, but long-term collaborations are welcome. Zlatomics leverages diverse client experience to provide cutting-edge insights into competitive scientific positioning, operational research bottlenecks, and emerging science industry trends.